1 Cash-Producing Stock with Promising Prospects and 2 That Underwhelm
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that excels at turning cash into shareholder value and two best left off your watchlist.
Two Stocks to Sell:
Accel Entertainment (ACEL)
Trailing 12-Month Free Cash Flow Margin: 4.7%
Established in Illinois, Accel Entertainment (NYSE:ACEL) is a provider of electronic gaming machines and interactive amusement terminals to bars and entertainment venues.
Why Do We Think ACEL Will Underperform?
- Sluggish trends in its video gaming terminals sold suggest customers aren’t adopting its solutions as quickly as the company hoped
- Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
- Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
Accel Entertainment is trading at $12.39 per share, or 12.7x forward P/E. If you’re considering ACEL for your portfolio, see our FREE research report to learn more.
Haemonetics (HAE)
Trailing 12-Month Free Cash Flow Margin: 19.5%
With roots dating back to 1971 and a mission to improve blood-related healthcare, Haemonetics (NYSE:HAE) provides specialized medical devices and software for blood collection, processing, and management across plasma centers, blood banks, and hospitals.
Why Does HAE Fall Short?
- Sales were flat over the last two years, indicating it’s failed to expand this cycle
- Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
- Subscale operations are evident in its revenue base of $1.33 billion, meaning it has fewer distribution channels than its larger rivals
At $78.83 per share, Haemonetics trades at 15.1x forward P/E. Read our free research report to see why you should think twice about including HAE in your portfolio.
One Stock to Watch:
Fastenal (FAST)
Trailing 12-Month Free Cash Flow Margin: 13.2%
Founded in 1967, Fastenal (NASDAQ:FAST) provides industrial and construction supplies, including fasteners, tools, safety products, and many other product categories to businesses globally.
Why Is FAST Interesting?
- Offerings are mission-critical for businesses and lead to a best-in-class gross margin of 45.4%
- Excellent operating margin of 20.4% highlights the efficiency of its business model
- Free cash flow margin grew by 5.1 percentage points over the last five years, giving the company more chips to play with
Fastenal’s stock price of $47.66 implies a valuation ratio of 35.2x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.